Literature DB >> 19192425

Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap.

Roger S McIntyre1, Natalie L Rasgon, David E Kemp, Ha T Nguyen, Candy W Y Law, Valerie H Taylor, Hanna O Woldeyohannes, Mohammad T Alsuwaidan, Joanna K Soczynska, Byungsu Kim, Maria T Lourenco, Linda S Kahn, Benjamin I Goldstein.   

Abstract

The metabolic syndrome and its components are associated with depressive symptomatology. This article discusses the rate of co-occurrence and the points of pathophysiologic commonality between the metabolic syndrome and major depressive disorder.

Entities:  

Mesh：

Year:  2009        PMID： 19192425     DOI： 10.1007/s11892-009-0010-0

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


  57 in total

Review 1.  Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.

Authors:  Todd D Gould; Husseini K Manji
Journal:  Neuropsychopharmacology       Date:  2005-07       Impact factor: 7.853

Review 2.  Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway.

Authors:  R R Girgis; J A Javitch; J A Lieberman
Journal:  Mol Psychiatry       Date:  2008-04-15       Impact factor: 15.992

Review 3.  Associations between bipolar disorder and metabolic syndrome: A review.

Authors:  Valerie Taylor; Glenda MacQueen
Journal:  J Clin Psychiatry       Date:  2006-07       Impact factor: 4.384

Review 4.  Insulin resistance in depressive disorders and Alzheimer's disease: revisiting the missing link hypothesis.

Authors:  Natalie L Rasgon; Heather A Kenna
Journal:  Neurobiol Aging       Date:  2005-10-11       Impact factor: 4.673

Review 5.  Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus.

Authors:  Kenneth Maiese; Simona Daniela Morhan; Zhao Zhong Chong
Journal:  Curr Neurovasc Res       Date:  2007-02       Impact factor: 1.990

6.  Exercise treatment for depression: efficacy and dose response.

Authors:  Andrea L Dunn; Madhukar H Trivedi; James B Kampert; Camillia G Clark; Heather O Chambliss
Journal:  Am J Prev Med       Date:  2005-01       Impact factor: 5.043

7.  Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

Authors:  L Lapidus; C Bengtsson; B Larsson; K Pennert; E Rybo; L Sjöström
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10

8.  Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study.

Authors:  David E Laaksonen; Hanna-Maaria Lakka; Leo K Niskanen; George A Kaplan; Jukka T Salonen; Timo A Lakka
Journal:  Am J Epidemiol       Date:  2002-12-01       Impact factor: 4.897

9.  Associations between anxiety, depression, and the metabolic syndrome.

Authors:  Michael R Skilton; Philippe Moulin; Jean-Louis Terra; Fabrice Bonnet
Journal:  Biol Psychiatry       Date:  2007-06-05       Impact factor: 13.382

10.  Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women.

Authors:  R K Kalkhoff; A H Hartz; D Rupley; A H Kissebah; S Kelber
Journal:  J Lab Clin Med       Date:  1983-10
View more
  46 in total

Review 1.  The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.

Authors:  Roger S McIntyre; Ka Young Park; Candy W Y Law; Farah Sultan; Amanda Adams; Maria Teresa Lourenco; Aaron K S Lo; Joanna K Soczynska; Hanna Woldeyohannes; Mohammad Alsuwaidan; Jinju Yoon; Sidney H Kennedy
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

2.  Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation.

Authors:  Jinling Hou; Zhao Zhong Chong; Yan Chen Shang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2010-05       Impact factor: 1.990

Review 3.  Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors:  Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal:  Neurotox Res       Date:  2010-06-15       Impact factor: 3.911

4.  Relationship between cumulative BMI and symptomatic, psychosocial, and medical outcomes in patients with borderline personality disorder.

Authors:  Frances R Frankenburg; Mary C Zanarini
Journal:  J Pers Disord       Date:  2011-08

5.  Depression and risk of type 2 diabetes: the potential role of metabolic factors.

Authors:  N Schmitz; S S Deschênes; R J Burns; K J Smith; A Lesage; I Strychar; R Rabasa-Lhoret; C Freitas; E Graham; P Awadalla; J L Wang
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

6.  Cognitive decline and cardiometabolic risk among Hispanic and non-Hispanic white adults in the San Luis Valley Health and Aging Study.

Authors:  Kerry L Hildreth; Jim Grigsby; Lucinda L Bryant; Pamela Wolfe; Judith Baxter
Journal:  J Behav Med       Date:  2013-01-18

7.  Basal ganglia morphology links the metabolic syndrome and depressive symptoms.

Authors:  Ikechukwu C Onyewuenyi; Matthew F Muldoon; Israel C Christie; Kirk I Erickson; Peter J Gianaros
Journal:  Physiol Behav       Date:  2013-10-04

8.  Metabolic and hormone influences on emotion processing during menopause.

Authors:  Alison Berent-Spillson; Courtney Marsh; Carol Persad; John Randolph; Jon-Kar Zubieta; Yolanda Smith
Journal:  Psychoneuroendocrinology       Date:  2016-09-05       Impact factor: 4.905

9.  Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study.

Authors:  Johanna Assies; François Pouwer; Anja Lok; Roel J T Mocking; Claudi L H Bockting; Ieke Visser; Nico G G M Abeling; Marinus Duran; Aart H Schene
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

Review 10.  The vitamin nicotinamide: translating nutrition into clinical care.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Molecules       Date:  2009-09-09       Impact factor: 4.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.